A prospective double-blind trial of a low molecular weight heparin once daily compared with a conventional low-dose heparin three times daily prevent pulmonary embolism and venous thrombosis in patients with hip fracture
- PMID: 2161934
A prospective double-blind trial of a low molecular weight heparin once daily compared with a conventional low-dose heparin three times daily prevent pulmonary embolism and venous thrombosis in patients with hip fracture
Comment on
-
A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.J Trauma. 1989 Jun;29(6):873-5. doi: 10.1097/00005373-198906000-00028. J Trauma. 1989. PMID: 2544742 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical